GenWorks Health has secured a second round of funding to Rs 135 crore from a consortium of investors named Somerset Indus Capital Partners, Morgan Stanley through its funding arm Grand Vista, Evolvence & Wipro GE. Now, the new startup aims to double the revenues by the year-end, and the funding will be leveraged to cover working capital needs, relevant M&A to invest in manufacturing partnerships, and expansion in the area of in-vitro diagnostics.

S Ganesh Prasad, Founder, MD & CEO, said, “Our goal at GenWorks has been crystal clear – to bring awareness for affordable care. The journey towards this began in 2015 in Mother and Child care, Critical Care & Cardiology, Radiology, and Hospital solutions. We started with 160 people in 30 locations with GE as the primary technology partner.”

“Today, we have a strategy to solve care cycle needs in every area as a part of our endeavour to support affordable access through 500+ people in over 130 locations. Technology is at the forefront of this healthcare transformation from healthcare delivery, ICU care disruption, urgent care or home care, to bringing efficiency in supply chain and commercial excellence.”